USPTO serial 76720911
BIOTYPE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 5, 2024
- Examiner
- OSGOOD, KRYSTINA E
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOTYPE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ROBERT S. BRODER
ROBERT S. BRODER COLLARD & ROE, P.C.1077 Northern Blvd.Roslyn, NY 11576United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemicals, chemical and biotechnological products, namely, biochemicals and chemicals for use in biotechnological manufacturing processes for industrial and scientific purposes; biochemicals, chemical and biotechnological products, namely, polynucleotides and monoclonal antibodies for scientific in vitro and in vivo applications; biochemicals, chemical and biotechnological products, namely, precursors for in vitro genetic engineering use; biochemicals and biotechnological products, namely, polypeptides for in vitro research use; biochemicals and biotechnological products, namely, monoclonal antibodies for in vitro scientific or research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemicals and biochemicals for research, laboratory and industrial purposes; chemical reagents for molecular biology, other than for medical or veterinary use; chemicals for use in the purification of proteins for in vitro use; chemicals for use in the purification of nucleic acids for in vitro use; chemical enzyme stabilizers for biological samples; reagents for stabilizing biological samples for research purposes; chemical reagents for multiplying nucleic acid amount, other than medical and veterinary purposes; chemicals for use in performing nucleic acid polymerase chain reactions for use in industry, other than medical and veterinary purposes; chemical preparations for use in the purification of proteins, polypeptides, and nucleic acids for in vitro use for scientific purposes; diagnostic reagents for in-vitro use for scientific or research use; diagnostic reagents for in-vitro use, other than medical use, namely, enzymes, oligonucleotides and buffer solutions for use in analytical chemistry for scientific or research use for enhancing, labeling and analysis of biopolymers and nucleic acids; diagnostic reagents for scientific use for in vitro use in biochemistry, clinical chemistry, molecular biology and microbiology; enzymes in liquid form for industrial use; enzymes for industrial purposes, other than medical purposes for labeling and for measuring proteins and protein fragments; kits, namely, testing kits containing peptide and nucleic acid substrates for labeling and analyzing biomolecules for laboratory or research use; kits for labeling and analyzing biomolecules, consisting primarily of reagents for scientific purposes; kits consisting primarily of chemicals, reagents, enzymes and buffer solutions used in analytical chemistry for research purposes; kits for labeling and analyzing biomolecules, namely, kits comprised primarily of unprocessed biopolymers and nucleic acids for laboratory use; nucleic acids for laboratory use; nucleic acids for scientific purposes; nucleic acid for use in nucleic acid amplification processes for laboratory use, other than for medical use; nucleic acid sequencing preparations other than for medical use; nucleic acid chemical reagents for use in forensic analysis, other than for medical purposes; reagents and unprocessed polymers in each case for use in environmental analyses, for geophysical analyses and for food analyses, all for scientific use; chemical reagents for microbiological analysis, other than for medical or veterinary purposes; nucleic acid amplification reagents for laboratory use; biochemicals, namely, monoclonal antibodies for scientific use, other than for medical or veterinary use; chemicals, namely, monoclonal antibodies for industrial use; tagged antibodies being biochemicals for laboratory use; antibody chemical reagents for scientific purposes; unprocessed polymers for use in the analysis of nucleic acids; proteins in raw material form for binding and detection of antibodies for scientific research, other than for medical purposes; diagnostic reagents for clinical or medical laboratory use | ACTIVE | Dec 18, 2019 |
| 005 | Medical and veterinary preparations, namely, diagnostic preparations for medical purposes used by medical laboratories; medical and veterinary preparations, namely, enzyme preparations for medical purposes; biological tissue cultures for veterinary purposes; biological tissue cultures for medical purposes; biological skin, tissue intended for subsequent implantation; diagnostic chemical reagents for medical use; chemical preparations being chemical reagents for use in DNA analysis for medical purposes; diagnostic preparations and materials, namely, diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; in vitro diagnostic preparations for medical or veterinary purposes; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents and assays for testing biological tissues; medical diagnostic reagents and assays for testing biological tissues, namely, living tissue and dead tissue; medical diagnostic reagents and assays for testing biological tissues, namely, living biopsy tissue and dead autopsy tissue; nucleic acid sequences for medical and veterinary purposes; radioactive preparations being radioactive substances for medical and veterinary diagnosis; reactants, namely, medical diagnostic reagents for medical and veterinary diagnosis; chemical and [ bochemical ] * biochemical * reagents for diagnostic tests for medical purposes; reagents for medical and veterinary diagnostic purposes; reagents for medical and veterinary diagnostic medicine tests; clinical diagnostic reagents for medical use; reagents for veterinary and medical purposes; reagents and media for use in diagnostic tests for medical or veterinary purposes; diagnostic reagents for use with analyzers for medical and veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions | ACTIVE | Dec 18, 2019 |
| 009 | Scientific research and laboratory apparatus, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific research and laboratory apparatus, namely, capillary electrophoresis apparatus, not for medical purposes; teaching apparatus, namely, medical diagnostic simulators for use as teaching aids for analysis of DNA or RNA; scientific laboratory apparatus and instruments for extracting nucleic acid, DNA, RNA and proteins; scientific apparatus and instruments, namely, medical laboratory research instruments for detecting and DNA analysis; research apparatus and instruments, namely, electrophoresis apparatus not for medical purposes; capillary tubes for samples for laboratory use; capillary tubes for blood for laboratory use; solid phase extraction cartridges for laboratory use; laboratory apparatus and instruments, namely, hand-operated laboratory tools for manipulating laboratory samples; laboratory apparatus and instruments, namely, laboratory centrifuges for carrying out molecular biological measurements; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; devices, namely, nano-particle size analyzers for analyzing genome information; devices, namely, laboratory centrifuges for carrying out molecular biological measurements; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; nucleic acid sequencers for scientific purposes; quantitative polymerase chain reaction (PCR) instruments for scientific use, namely, medical laboratory research instruments for DNA analysis; DNA chips; DNA microarray; biochips for research or scientific purposes; bio-sensors being sensor chips for scientific use; bioreactors for laboratory use; laboratory chemical reactors; diagnostic apparatus for the detection of pathogens for laboratory or research use, not for medical purposes; disposable plastic bioreactors for biological samples for cell culturing; real-time polymerase chain reaction (PCR) instruments for scientific use, namely, medical laboratory research instruments for DNA analysis; electrophoresis apparatus, not for medical purposes; downloadable application software for document management; application software, namely, integrated software packages comprised of downloadable software for use in laboratory automation for integrating manufacturing machine operations, track problems and generate production reports; downloadable computer operating software for use in medical decision support systems; software for monitoring, analyzing, controlling and running physical world operations, namely, downloadable bioinformatics operating software for monitoring, analyzing, and controlling laboratory machines; downloadable optical mark recognition (OMR) software for recognizing marks made of paper form | ACTIVE | Dec 18, 2019 |
| 042 | Science and technological services, namely, scientific laboratory services; science and technology services, namely, scientific research, tests and analyses for others in the field of amplification, labeling and analysis of biopolymers and nucleic acids; science and technology services, namely, contract scientific research services in the field of molecular science; services of a chemical and biochemical laboratory, namely, scientific laboratory services; design and development of quality control measuring and testing standards in the field of chemical production; research and development of new products for others; design and testing for new product development; design and development of new technology for others in the nature of software; design and development of diagnostic laboratory devices and instruments; design and development of medical diagnostic apparatus; preparation of scientific reports being providing scientific research information; creating and further developing programs being design and development of software programs for data processing; scientific testing services in the field of in the field of molecular diagnostics; scientific testing services in the field of molecular biology; carrying out molecular biological, biochemical and immunological analyses being chemical analysis services; natural science services, namely, consultation in the field of molecular biology; technological and advisory services relating to science, namely, scientific research consulting; scientific research and development in the field of biochemistry, gene expression systems and immunology; scientific research and development in the field of diagnostic preparations; scientific research and development in the field of pharmacy, biotechnology, of microorganisms and cells; product testing, authentication of data in the field of diagnostics and quality control for others; testing, authentication and quality control, namely, computer-truncated diagnostic test services being testing of computer diagnostic software; testing, authentication and quality control, namely, computer-supported diagnostic product quality test services; quality control for others; IT services, namely, website hosting services; software as a service (SAAS) services featuring software for analyzing and reporting scientific findings, and rental of computer operating software; platform as a service (PAAS) featuring computer software platforms for database management; platform as a service (PAAS) featuring computer software platforms for analyzing data for molecular biological analyses | ACTIVE | Nov 5, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biotype GmbH
- Other trademarks owned by Biotype GmbH
- Other trademarks owned by Biotype GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named BIOTYPE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 13, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Apr 21, 2025 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 18, 2025 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Apr 10, 2025 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Apr 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 12, 2024 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Nov 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 20, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 9, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 9, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 9, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 16, 2024 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Feb 14, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 20, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 19, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 19, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 19, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 19, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 27, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2023 | TRPT | REQUEST FOR TRANSFORMATION PROCESSED - TOTAL | — |
| Oct 3, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 28, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |